Century Therapeutics
Latest round
- Series C
Last raised
- Feb 2021
Total raised
- $410M
Investors
- 14
About Century Therapeutics
Founded in 2018 and based in Pennsylvania, US, Century Therapeutics, Inc. operates as a biotechnology company that develops induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology. The company has 107 employees as of April 2021. In June 2021, Century Therapeutics, Inc.6 million shares at USD 20 per share on the NASDAQ. It trades on NASDAQ under the ticker symbol IPSC. Century Therapeutics is harnessing the power of adult stem cells to develop curative cell therapy products for cancer. The company's genetically engineered, iPSC-derived iNK and iT cell products are designed to specifically target hematologic and solid tumor cancers. These products are designed to resist host rejection, enhance cell persistence, and allow repeat dosing to provide durable responses in all patients.
Who invested in Century Therapeutics
14 investors across 2 rounds
See all investors in Century Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Century Therapeutics
Who invested in Century Therapeutics?
Century Therapeutics has 14 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Century Therapeutics raised?
Century Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Century Therapeutics last raise money?
Century Therapeutics's most recent round on record is a Series C, in Feb 2021.
What does Century Therapeutics do?
Founded in 2018 and based in Pennsylvania, US, Century Therapeutics, Inc.
Where is Century Therapeutics headquartered?
Century Therapeutics is headquartered in Philadelphia, US.
Which VCs invest in companies like Century Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Century Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Century Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.